Abstract
Cell-free protein synthesis (CFPS) has emerged as a powerful platform technology to help satisfy the growing demand for simple, affordable, and efficient protein production. In this article, we describe a novel CFPS platform derived from the popular bio-manufacturing organism Saccharomyces cerevisiae. By developing a streamlined crude extract preparation protocol and optimizing the CFPS reaction conditions we were able to achieve active firefly luciferase synthesis yields of 7.7±0.5μgmL-1 with batch reactions lasting up to 2h. This duration of synthesis is the longest ever reported for a yeast CFPS batch reaction. Furthermore, by removing extraneous processing steps and eliminating expensive reagents from the cell-free reaction, we have increased relative product yield (μg protein synthesized per $ reagent cost) over an alternative commonly used method up to 2000-fold from ~2×10-4 to ~4×10-1μg$-1, which now puts the yeast CPFS platform on par with other eukaryotic CFPS platforms commercially available. Our results set the stage for developing a yeast CFPS platform that provides for high-yielding and cost-effective expression of a variety of protein therapeutics and protein libraries.
Original language | English (US) |
---|---|
Pages (from-to) | 2643-2654 |
Number of pages | 12 |
Journal | Biotechnology and Bioengineering |
Volume | 110 |
Issue number | 10 |
DOIs | |
State | Published - Oct 2013 |
Keywords
- Cell-free biology
- Cell-free protein synthesis
- In vitro translation
- Protein expression
- Saccharomyces cerevisiae
ASJC Scopus subject areas
- Applied Microbiology and Biotechnology
- Bioengineering
- Biotechnology